Department of Internal Medicine, Krankenhaus Barmherzige Brüder, Johannes von Gott-Platz 1, A-1020 Vienna, Austria.
Bone. 2011 Oct;49(4):824-9. doi: 10.1016/j.bone.2011.06.003. Epub 2011 Jun 12.
Although it is well known that body mass index (BMI) and bone mineral density (BMD) are positively correlated, the mechanisms by which adiposity reduces the risk of osteoporotic fractures are not fully understood. The present study was initiated to gain deeper insight into the mechanisms underlying the osteoprotective effect of adiposity, and to assess particularly the relevance that BMI-associated changes in circulating hormone levels could have for the build-up of additional bone mineral density. Using data from a previous study on a large cohort of healthy adult Austrians, we analyzed correlations of BMI with (i) BMD at sites in the lumbar spine and hip region, (ii) bone resorption and formation markers, (iii) circulating levels of vitamin D, parathyroid hormone, testosterone and estrogen, and (iv) rates of daily vitamin D and calcium intake. After adjustment for age, positive correlations between BMI and BMD were highly significant (P<0.0001) at all skeletal sites across the entire study cohort. Associations were stronger in post-menopausal women than in pre-menopausal women and in men. In absolute values, the gain in BMD at the lumbar spine from an incremental rise of BMI in post-menopausal women was 1.5-fold higher than in pre-menopausal women, and three times of that observed in men (P<0.05). Inverse relations between BMI and β-crosslaps were consistently found in men (P<0.01) and in women before and after menopause (P<0.01 and P<0.05, respectively), suggesting that inhibition of osteoclastic bone resorption is responsible at least in part for the positive effect of high BMI on BMD. Sub-group analysis revealed that increasing BMI was associated with a significant fall of testosterone in men (P<0.05), and of 25-(OH)D in pre- and post-menopausal women (P<0.001 and P<0.05, respectively), but with a significant rise in PTH (P<0.01) in women before menopause. Since all these hormonal changes would cause bone loss, this excludes their playing any role in the osteoprotective effect of adiposity.
尽管众所周知,体重指数(BMI)和骨密度(BMD)呈正相关,但脂肪含量降低骨质疏松性骨折风险的机制尚未完全阐明。本研究旨在深入了解脂肪含量的骨保护作用的机制,并特别评估与 BMI 相关的循环激素水平变化对额外骨密度积累的相关性。我们使用来自奥地利一项大型健康成年人队列研究的数据,分析了 BMI 与(i)腰椎和髋部区域的 BMD、(ii)骨吸收和形成标志物、(iii)循环维生素 D、甲状旁腺激素、睾酮和雌激素水平、(iv)每日维生素 D 和钙摄入量之间的相关性。在调整年龄后,BMI 与整个研究队列所有骨骼部位的 BMD 之间存在高度显著的正相关(P<0.0001)。在绝经后女性中,这种相关性强于绝经前女性和男性。从绝对值来看,绝经后女性中 BMI 每增加 1 个单位,腰椎 BMD 的增加幅度是绝经前女性的 1.5 倍,是男性的 3 倍(P<0.05)。在男性(P<0.01)和绝经前和绝经后女性(P<0.01 和 P<0.05)中,BMI 与β-交联胶原之间始终存在负相关,这表明抑制破骨细胞骨吸收至少部分解释了高 BMI 对 BMD 的积极影响。亚组分析显示,BMI 的增加与男性的睾酮水平显著下降(P<0.05)以及绝经前和绝经后女性的 25-(OH)D 水平显著下降(P<0.001 和 P<0.05)相关,但绝经前女性的甲状旁腺激素(PTH)水平显著升高(P<0.01)。由于所有这些激素变化都会导致骨丢失,因此排除了它们在脂肪含量的骨保护作用中的任何作用。